Earnings Call · Q2 FY2024·2024-08-09

Q2 24EPS -19.74%·Rev n/aQ1 24EPS -50.68%·Rev n/aQ4 23EPS +24.56%·Rev n/aQ3 23EPS +22.06%·Rev n/a⚠ consensus missing

AVITA Medical, Inc. RCEL

Jessica Ekeberg — Investor Relations

Jim Corbett — Chief Executive Officer

David O'Toole — Chief Financial Officer

+20.7%1d on move date+20.2% vs SPY3d+21.2%5d+17.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCEL calls or request research access.

More RCEL calls Browse calls Request research access